Rezvilutamide (SHR3680) is an orally available androgen receptor inhibitor that crosses the blood-brain barrier and has antitumor activity.Rezvilutamide (SHR3680) is used in the study of metastatic desmoplasia-resistant prostate cancer.
Molekulargewicht:
479.47
Reinheit:
0.9997
CAS Nummer:
[1572045-62-5]
Formel:
C22H20F3N3O4S
Target-Kategorie:
Androgen Receptor
T39044
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten